|
PubHealth.info®
(a subsidiary of
PakMed) presents scientific information mainly
based on abstracts of articles published on a variety of public health issues/topics,
particularly encompassing
population planning, disease prevention, maternal and child health,
and communicable and
non-communicable diseases (like HIV AIDS, malaria, etc) that are
affecting a significant portion of population in developing and
developed
countries. Here you can find abstracts of articles published on a variety of public health
topics under category "Contraception
(Birth Control) and Family Planning".
Contraception (birth control)
is a regimen of one or more actions, devices, or medications followed in
order to deliberately prevent or reduce the likelihood of a woman
becoming pregnant or giving birth. Therefore contraception is the
utilization of various and sundry surgical procedures, devices,
practices, agents, or drugs with the intention of preventing conception
or impregnation (pregnancy). Methods and intentions typically termed
birth control may be considered a pivotal ingredient to family
planning. Birth control is a controversial political and ethical
issue in many cultures and religions, and although it is generally less
controversial than abortion specifically. |
|
|
| CATEGORY: |
Contraception (Birth Control) and Family Planning |
| New contraceptive technologies. |
| In: Dimensions of new contraceptives: Norplant and poor women, edited by |
| Sarah E. Samuels, Mark D. Smith. Menlo Park, California, Henry J. Kaiser Family |
| Foundation, 1992. :83-95. |
| By taking a hypothetical leap 10 years into the future, Gary Grubb of Family Health International's Clinical Trials |
| Division develops a scenario for contraceptive technology in the 1900s. Norplant's introduction coincided with the |
| end of a decade of stagnation in contraceptive development stimulated, in part, by concerns about product liability |
| litigation. Over time, other long-acting steroid contraceptives that had a shorter duration of action than Norplant, |
| required less provider training, and were less costly to purchase emerged. Other contraceptives introduced in the |
| early 1900s included oral contraceptives containing new progestins (desogestrel, gestodene, and norgestimate) and |
| with less effect on blood cholesterol levels, female condoms that enabled women to protect themselves from the |
| transmission of sexually transmitted diseases, stronger male condoms made from various types of plastic, a |
| sterilization device (Filshie clip) that occluded only 3 mm of the fallopian tube, and more flexible IUDs that minimized |
| contact with the endometrium. In the late 1990s, steroid-releasing vaginal rings and progestin-estrogen patches |
| were introduced. These innovations eliminated the irregular menstrual bleeding that limited the acceptability of |
| implants and returned control over removal to the woman. The majority of advances in contraceptive technology |
| during the 1990s represented refinements of existing methods. During the first decade of the 21st century, advances |
| are projected to center around immunocontraception, male pills and injectables, and oral contraceptives with |
| different modes of action. (PubHealth.info Document ID: CONT3T 1577-06) |
| PubHealth.info NOTE: The author(s) of this article titled, "New contraceptive technologies.", is(are) Grubb GS. The |
| source of this article is "In: Dimensions of new contraceptives: Norplant and poor women, edited by Sarah E. |
| Samuels, Mark D. Smith. Menlo Park, California, Henry J. Kaiser Family Foundation, 1992. :83-95.". This article was |
| published in 1992 in English language(s). (PubHealth.info® Document ID: CONT3T 1577-06. All rights reserved with |
| PubHealth.info) PIN: 11577 |
|
|
|
© Copyrights PubHealth.info®,
an information portal on public health. All rights
reserved.
This page is optimized to be viewed by
Java script enabled Microsoft®
Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels. |